Prostate cancer.
D000726:Androgen Antagonists / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant; D005485:Flutamide / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009765:Obesity / Q000453:epidemiology; D011379:Prognosis; D017430:Prostate-Specific Antigen / Q000097:blood; D011468:Prostatectomy / Q000009:adverse effects; D011471:Prostatic Neoplasms / Q000401:mortality / Q000628:therapy; D014525:Urethral Stricture / Q000209:etiology / Q000628:therapy
D000726:Androgen Antagonists; D000970:Antineoplastic Agents; D005485:Flutamide; D017430:Prostate-Specific Antigen